Several of the studies presented in this article displayed that modification of cadherin expression, often upregulation of E-cadherin and downregulation of N-cadherin, resulted in a decreased rate of EMT and subsequent decreased malignant potential of osteosarcoma cell lines in vitro [36, 40, 41]. The gene discussed is CDH1; the disease is osteosarcoma.